Skip to main content
    C

    Co-Diagnostics, Inc. Common Stock (CODX)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $0.22
    -0.03 (-13.03%)

    Market Cap: $2.72M

    Last updated: Nov 17, 2026 at 11:03 AM ET

    Co-Diagnostics, Inc. Common Stock (CODX) Valuation Multiples

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    Co-Diagnostics, Inc. Common Stock (CODX) trades at 1.6x sales and 0.1x book value. Its P/S of 1.6x is below its 5-year median of 3.8x. Its forward P/E is 15.4x.

    Current Multiples

    MultipleValue
    P/E (trailing)N/A
    Forward P/E15.4x
    Price to sales1.6x
    Price to book0.1x
    PEGN/A
    FCF yield-1927.4%
    As of Nov 17, 2026

    Historical Medians

    Against its 10-year medians, its P/B is 90.9% below 1.1x.

    MultipleCurrent5-year median10-year median
    P/S1.6x3.8xN/A
    P/B0.1x0.4x1.1x
    Medians of month-end values through Oct 2026: 60 months (5-year) and 102 months (10-year).

    Valuation History

    Over the 3 of the 9 year ends shown that have a P/E, its P/E ranged from 9.1x in 2021 to 45.3x in 2022.

    Year endPriceP/EP/SP/B
    2025$5.06N/A10.0x0.3x
    2024$22.52N/A5.8x0.5x
    2023$39.94N/A5.9x0.5x
    2022$75.6845.3x2.4x0.7x
    2021$268.179.1x2.7x2.0x
    2020$279.2810.1x3.5x3.9x
    2019$26.88N/A81.6x11.8x
    2018$44.74N/AN/AN/A
    2017$79.28N/AN/A179.5x
    Each year's multiples use the split-adjusted closing price of that year's last trading day over trailing per-share results as reported; periods with losses are left out.

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About CODX

    What is CODX's forward P/E ratio?

    Co-Diagnostics, Inc. Common Stock has a forward P/E ratio of 15.4x.

    Is CODX stock overvalued?

    GNG's valuation label for CODX is Undervalued.

    What is CODX's price to sales ratio?

    Co-Diagnostics, Inc. Common Stock has a price to sales ratio of 1.6x.